More than half of all donated organs are rejected because they cannot reach patients fast enough.
We’re about to change that by extending viability from 4 to 24 hours.
There’s not enough time for donated organs.
Right now, most organs are rejected because they can’t reach patients in time.
Let’s change the organ transplant world.
By extending the viability of organs from 4 hours to 24 hours, more organs will be available for transplant, and more lives will be saved.
Why 24 hours is transformational
ULiSSES™ is a game-changer.
The very first organ ever transplanted was placed in a cooler and packed in ice, and that is still how most organs are preserved 65 years later. This is unacceptable. Vascular Perfusion Solutions (VPS) is working with a team of world-class scientists to perfect ULiSSES™, a device designed to perfuse and resuscitate tissue, allowing organs and limbs to remain viable for more than 24 hours.
Our next round of research
The ULiSSES™ device has already been successfully tested in small animal studies, but now large animal studies must be conducted so that human testing can follow. These steps are important if we are to finally change the world of organ transplantation.
Ask a Question
Have a question? Fill out the form below.
Here you can read about some of our early investigation and technology development.
Preserving Limbs in 21st Century
For those that are interested in learning more about the state of the art in machine perfusion for kidneys, the following article is available:
Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation – Tingle, SJ – 2019 | Cochrane Library
This paper, authored by the inventor of ULiSSESTM, illustrates the advantages of oxygenated perfusion. We are excited to note that the ULiSSESTM technology is quite different from what is illustrated in this paper. It is much more efficient, and represents a dramatic improvement in the ability of the device to keep organs and limbs alive. Patent applications are pending.
Novel portable hypothermic pulsatile perfusion preservation technology: Improved viability and function of rodent and canine kidneys